InsidersTradesSigma
Explore the full record of transactions filed by Hoffman Robert E., Chairman & CEO. Director active across 1 companies, notably Kintara Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €46k. The latest transaction was filed on 15 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Hoffman Robert E. is the President and CEO of Kintara Therapeutics, Inc. He is responsible for the strategic direction of the company, ensuring that development objectives are met. His leadership is essential for navigating the biotechnology sector.